Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of cypofol to suppress cardiovascular responses to double-lumen tracheal intubation under sufentanil anesthesia
ChiCTR2300078707Phase 4Recruiting
- Sponsor
- Henan Provincial People's Hospital
- Start
- Dec 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cypofol (2 arms), sponsored by Henan Provincial People's Hospital. Primary endpoints: Blood pressure and Heart rate. Started Dec 2023; status: recruiting.
02
Drugs
cypofol
Beyond the preview
Go deeper on ChiCTR2300078707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078707.